Early research (Phase 1)Study completedNCT07264335
What this trial is testing
A Study on the Bioavailability of SHR-1819 Injection Administered Subcutaneously Using Different Injection Devices in Healthy Subjects
Who this might be right for
Atopic Dermatitis
Guangdong Hengrui Pharmaceutical Co., Ltd 160